Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine (CROSBI ID 86510)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Žanić-Grubišić, Tihana ; Zrinski, Renata ; Čepelak, Ivana ; Petrik, Jozef ; Radić, Božica ; Pepeljnjak, Stjepan Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine // Toxicology and applied pharmacology, 167 (2000), 2; 132-139-x

Podaci o odgovornosti

Žanić-Grubišić, Tihana ; Zrinski, Renata ; Čepelak, Ivana ; Petrik, Jozef ; Radić, Božica ; Pepeljnjak, Stjepan

engleski

Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine

Ochratoxin A(OTA) is a nephrotoxic, hepatotoxic, and teratogenic mycotoxin produced by storage molds ona a variety of foodstuffs. Its chemical structure is composed of an isocumarin part linked to L-phenylalanine. Inhibition of phenylalanine hydroxylase and other enzymes that use phenylanine as substrate is based on this structural homology. We have examined the effects of low doses of ochratoxin A on the acitivity of phenylanine hydroxylase in kidney and in liver of experimental animals. Daily administration of ochratoxin A (5 ug/kg bw, for 10 and 35 days, respectively) caused a significant reduction in phenylalanine hydrohylase activity. Inhibition was more pronounced in liver than in kidney, although actual ochratoxin A concentration was higher in the kidney tissue. We observed an apparent increase in the affinity of phenylanine hydroxylase for substrate following OTA administration to animals. However, simple competitive inhibition was observed for both tissues in vitro. Simultaneous application of ochratoxin A with phenylanine could reduce inhibition of phenylanine hydroxylase, in particular in liver. Enzyme acitivity was almost completely preserved after 35 days of combined treatment. The results obtained suggest that daily administration of ochratoxin A in low doses produced an inhbitory effect that could be diminished by competitive action of L-phenylanine.

ochratoxin A; phenylanaine hydroxylase; experimental endemic nephropathy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

167 (2)

2000.

132-139-x

objavljeno

0041-008X

Povezanost rada

Farmacija, Kliničke medicinske znanosti

Indeksiranost